International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024

The 25th Anniversary Edition of the International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024 took place as a hybrid workshop from 18-19 September 2024 in Liverpool, United Kingdom. 

The International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs gathers leading experts to discuss all aspects of the optimal use of antiviral therapy including drug-drug interactions, pharmacokinetics of investigational and existing drugs, pharmacodynamics, drug dosing in under-represented populations, post-marketing surveillance, and regulatory considerations.

General Information 

Practical Information 

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

• Vikram Arya, PhD, FCP - Food and Drug Administration, United States
• Kristina Brooks, PharmD - University of Colorado Anschutz Medical Campus, United States
• Andrea Calcagno, MD, DTM&H - University of Turin, Italy
• Su-Young Choi, PharmD, PhD - Food and Drug Administration, United States
• Angela Colbers, PhD - Radboud University Medical Center, the Netherlands
• Paolo Denti, PhD - University of Cape Town, South Africa
• Tanuja N. Gengiah, B.Pharm, MClinPharm, Ms(Epi), PhD - Centre for the AIDS Programme of Research (CAPRISA) & University of KwaZulu-Natal, South Africa
• Mohammed Lamorde, MD - Infectious Diseases Institute, Uganda
• Minh Patrick Lê, PhD - Hôpital Bichat-Claude Bernard, France
• Lawrence Lee, MBBS, PhD - National University of Singapore, Singapore
• Catia Marzolini, PharmD, PhD - University Hospital Basel, Switzerland & University of Liverpool, United Kingdom
• Steve Taylor, MRCP, PhD - Birmingham Heartlands Hospital, United Kingdom
• Catriona Waitt, MBChB, PhD - University of Liverpool, United Kingdom 
• Julie Dumond, Pharm.D., M.S. - UNC Eshelman School of Pharmacy,United States

The members of the Academic Advisory Board (AAB) are former members of the OC and remain active the in planning of the program for the next year. Members of the current OC are selected from this group. 

• David Back, PhD - University of Liverpool, United Kingdom
• Terrence Blaschke, MD - Stanford University School of Medicine, United States
• Marta Boffito, MD, PhD, FRCP - Chelsea and Westminster Hospital London, United Kingdom
• David Burger, MD, PhD - Radboud University Medical Center, the Netherlands
• Giovanni Di Perri, MD, PhD - University of Torino, Italy
• Courtney Fletcher, PharmD - University of Nebraska Medical Center, United States
• Charles Flexner, MD - Johns Hopkins University, United States
• Angela Kashuba, PharmD - University of North Carolina at Chapel Hill, United States
• Jürgen Rockstroh, MD - University of Bonn, Germany
• Jonathan Schapiro, MD - National Hemophilia Center, Sheba Medical Center, Israel

The Industry Liaison Board, consisting of leading medical scientists of the pharmaceutical industry, is asked to give input and suggestions that help the Organizing Committee in planning the workshop and providing support on topics of interest and innovative suggestions to optimize audience participation. The Industry Liaison Board assists the Organizing Committee by suggesting the most current and critical topics to bring the audience up-to-date on the most current research in the pharmaceutical industry in related disciplines.

• Wei Liu - AbbVie
• Thomas Kakuda - Janssen, Pharmaceutical Companies of Johnson and Johnson
• Xiao-Jian Zhou - ​​​​​​Atea Pharmaceuticals
• Simon Portsmouth - Shionogi

Financial backing to the International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024 helps us deliver an impactful meeting experience for the benefit of healthcare professionals, researchers, and community representatives involved in clinical pharmacology of HIV, Hepatitis, and other antiviral drugs.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.

To show your commitment to the cause, get in touch with us for a tailored support package by contacting Jesper Niesen at Jesper.Niesen@amededu.com or call +31 30 230 7140.
 
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

• Symposium opportunities
• Non-commercial interviews with company representatives
• Verbal acknowledgement during the program 
• Discounted and complimentary registrations for your representatives
• Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
• Company acknowledgement on printed meeting materials including but not limited to banners and the program book
• Digital and printed advertising opportunities 
• Social media shout-outs
• Logo on the conference bag 

 
*Subject to the support level.

Invitation from Saye Khoo, MD, PhD, Royal Liverpool University Hospital; University of Liverpool, United Kingdom.

• 24th Edition - International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs, 2023, Rome

• 23rd Edition - International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs, 2022, Spain

• 22nd Edition - International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs, 2021, Virtual
• 21st Edition - International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs, 2020, Virtual
• 20th Edition - International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs, 2019, The Netherlands
• 19th Edition - International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs, 2018, United States
• 18th Edition - International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs, 2017, United States
• 17th Edition, International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs, 2016, United States